VEGF News and Research

RSS
VEGF is a substance made by cells that stimulates new blood vessel formation. Also called vascular endothelial growth factor.
TGen-UNM consortium awarded NIH grant to discover new treatments for diabetic blindness

TGen-UNM consortium awarded NIH grant to discover new treatments for diabetic blindness

CHMP provides positive opinion to Cabometyx for previously-treated patients with hepatocellular carcinoma

CHMP provides positive opinion to Cabometyx for previously-treated patients with hepatocellular carcinoma

Ipsen receives approval from Health Canada for CABOMETYX tablets for treating renal cell carcinoma

Ipsen receives approval from Health Canada for CABOMETYX tablets for treating renal cell carcinoma

Study: aPKC inhibitors may provide new therapeutic option for blinding eye diseases

Study: aPKC inhibitors may provide new therapeutic option for blinding eye diseases

NCCN updates Clinical Practice Guidelines to include new recommendations for CABOMETYX tablets

NCCN updates Clinical Practice Guidelines to include new recommendations for CABOMETYX tablets

Additional inhibitor could be key to helping anti-VEGF therapies overcome resistance in glioblastoma

Additional inhibitor could be key to helping anti-VEGF therapies overcome resistance in glioblastoma

Saving sight of millions by making eye injections safe and comfortable

Saving sight of millions by making eye injections safe and comfortable

Scientists move one step further in developing eye drops to treat age-related macular degeneration

Scientists move one step further in developing eye drops to treat age-related macular degeneration

Ocular Therapeutix resubmits NDA for DEXTENZA

Ocular Therapeutix resubmits NDA for DEXTENZA

Researchers explore targeted second-line treatment for colorectal cancer

Researchers explore targeted second-line treatment for colorectal cancer

Researchers develop injectable bandage to stop fatal blood loss, activate wound healing

Researchers develop injectable bandage to stop fatal blood loss, activate wound healing

PanOptica doses first patient in Phase 1/2 dose-ranging clinical trial of PAN-90806

PanOptica doses first patient in Phase 1/2 dose-ranging clinical trial of PAN-90806

Non-aspirin NSAID use linked to shorter survival in patients with metastatic renal cell carcinoma

Non-aspirin NSAID use linked to shorter survival in patients with metastatic renal cell carcinoma

Neonicotinoids may impact human health by disrupting hormonal systems, shows study

Neonicotinoids may impact human health by disrupting hormonal systems, shows study

Ludwig scientists develop and test individualized ovarian cancer vaccine

Ludwig scientists develop and test individualized ovarian cancer vaccine

Novel biomarker helps optimize anticancer therapy

Novel biomarker helps optimize anticancer therapy

Vascular stabilization biomarker helps optimize timing of anticancer therapies

Vascular stabilization biomarker helps optimize timing of anticancer therapies

Research reveals neuroprotective mechanisms of gene and cell medications for spinal cord injuries

Research reveals neuroprotective mechanisms of gene and cell medications for spinal cord injuries

New marker involved in lymphatic system linked to increased risk of heart failure

New marker involved in lymphatic system linked to increased risk of heart failure

Geneva researchers highlight new way to control tumor progression

Geneva researchers highlight new way to control tumor progression